
Levofloxacin
CAS No. 100986-85-4
Levofloxacin ( Levofloxacin, Levaquin, Tavanic, Iquix, Quixin )
产品货号. M17748 CAS No. 100986-85-4
左氧氟沙星是一种广谱抗生素拓扑异构酶 II 和拓扑异构酶 IV 抑制剂,用于治疗呼吸道、泌尿道、胃肠道和腹部感染。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
100MG | ¥389 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Levofloxacin
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述左氧氟沙星是一种广谱抗生素拓扑异构酶 II 和拓扑异构酶 IV 抑制剂,用于治疗呼吸道、泌尿道、胃肠道和腹部感染。
-
产品描述Levofloxacin is an antibiotic. It is used to treat a number of bacterial infections including acute bacterial sinusitis, pneumonia, urinary tract infections, chronic prostatitis, and some types of gastroenteritis. Along with other antibiotics it may be used to treat tuberculosis, meningitis, or pelvic inflammatory disease. It is administered by mouth or intravenously.(In Vitro):Levofloxacin shows inhibition effects to M. tuberculosis susceptible strains OFLO, LVFX, and SPFX with MIC50 values of 1.0, 0.5 and 0.25 μg/mL, respectively。(In Vivo):Levofloxacin (10.7 mg/kg; i.p., once daily for 10 days or 3 weeks) time-dependently induces toxic effects on liver and heart in albino mice.
-
体外实验——
-
体内实验Animal Model:Matured male Albino miceDosage:10.7 mg/kg Administration:Intraperitoneal injection; 10.7 mg/kg, once daily for 10 days or 3 weeks.Result:Induced severe congestion of blood vessels in the portal area, central veins with inflammatory cells infiltration, necrosis with pyknosis of cardiac muscle nuclei and apoptosis, degeneration and necrosis of hepatocytes.
-
同义词Levofloxacin, Levaquin, Tavanic, Iquix, Quixin
-
通路Angiogenesis
-
靶点JAK
-
受体Topo II| Topo IV
-
研究领域Infection
-
适应症——
化学信息
-
CAS Number100986-85-4
-
分子量361.37
-
分子式C18H20FN3O4
-
纯度>98% (HPLC)
-
溶解度H2O : 50 mg/mL 138.36 mM; DMSO : 10 mg/mL 27.67 mM
-
SMILES[H][C@]1(C)COC2=C(N3CCN(C)CC3)C(F)=CC3=C2N1C=C(C(O)=O)C3=O
-
化学全称(S)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Davis R, et al. Drugs,1994, 47(4), 677-700.
产品手册




关联产品
-
JAK3-IN-2
一种有效且高度选择性的 JAK3 抑制剂,IC50 为 0.15 nM。
-
Axltide
Axltide is based on the mouse Insulin receptor substrate 1 (amino acid 979-989).Peptide sequence (KKSRGDYMTMQIG) is based on the mouse Insulin receptor substrate 1 (amino acid 979-989).
-
LY2784544
LY2784544 (Gandotinib) 是一种有效的、选择性的、ATP 竞争性的 JAK2V617F 抑制剂。